Impact of smoking cessation and lifetime exposure on C-reactive protein

Nicotine and Tobacco Research

Volumn 10, Issue 4, 2008, Pages 637-642

  Hastie, Claire E ^a   Haw, Sally ^b   Pell, Jill P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CIGARETTE SMOKE; COTININE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE MIX; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PASSIVE SMOKING; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; UNIVARIATE ANALYSIS;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SCOTLAND; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO SMOKE POLLUTION;

EID: 42449161515     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200801978722     Document Type: Article

References (35)

1. Bain, B. J., Rothwell, M., Feher, M. D., Robinson, R., Brown, J. and Sever, P. S. (1992) Acute changes in haematological parameters on cessation of smoking. Journal of the Royal Society of Medicine, 85:2, pp. 80-82.
2. Bakhru, A. and Erlinger, T. P. (2005) Smoking cessation and cardiovascular disease risk factors: Results from the Third National Health and Nutrition Examination Survey. Public Library of Science Medicine Journal, 2:6, p. e160.
3. Barnoya, J. and Glantz, S. A. (2005) Cardiovascular effects of secondhand smoke: Nearly as large as smoking. Circulation, 111:20, pp. 2684-2698.
4. Bazzano, L. A., Jiang, H., Muntner, P., Vupputuri, S. and Whelton, P. K. (2003) Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Annals of Internal Medicine, 138, pp. 891-897.
5. Casas, J. P., Shah, T., Cooper, J., Hawe, E., McMahon, A. D., Gaffney, D., Packard, C. J., O'Reilly, D. S., Juhan-Vague, I., Yudkin, J. S., Tremoli, E., Margaglione, M., Minno, G. Di, Hamsten, A., Kooistra, T., Stephens, J. W., Hurel, S. J., Livingstone, S., Calhoun, H. M., Miller, G. J., Bautista, L. E., Meade, T., Sattar, N., Humphries, S. E. and Hingorani, A. D. (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomisation. International Journal of Epidemiology, 35:4, pp. 922-931.
6. Corwin, E. J. and Klein, L. C. (2003) C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence. Human Psychopharmacology, 18:5, pp. 329-337.
7. Crook, M. A., Scott, D. A., Stapleton, J. A., Palmer, R. M., Wilson, R. F. and Sutherland, G. (2000) Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. European Journal of Clinical Investigation, 30, pp. 861-865.
8. Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, A., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B. and Gudnason, V. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350:14, pp. 1387-1397.
9. Dobson, A. J., Alexander, H. M., Heller, R. F. and Lloyd, D. M. (1991) How soon after quitting smoking does risk of heart attach decline?. Journal of Clinical Epidemiology, 44:11, pp. 1247-1253.
10. Doll, R., Peto, R., Boreham, J. and Sutherland, I. (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328, pp. 1519-1527.
11. Dunn, C. L., Pirie, P. L. and Hellerstedt, W. L. (2004) Self exposure to secondhand smoke among prenatal smokers, abstainers, and nonsmokers. American Journal of Health Promotion, 18:4, pp. 296-299.
12. Ernst, E. and Matrai, A. (1989) Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis, 64:1, pp. 75-77.
13. Frohlich, M., Sund, M., Lowel, H., Imhof, A., Hoffmeister, A. and Koenig, W. (2003) Independent association of various smoking characteristics with markers of systemic inflammation in men: Results from a representative sample of the general population (MONICA Ausburg Survey 1994/95). European Heart Journal, 24:14, pp. 1365-1372.
14. Haustein, K. O., Krause, J., Haustein, H., Rasmussen, T. and Cort, N. (2002) Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. Journal of Internal Medicine, 252, pp. 130-139.
15. Haverkate, F., Thompson, G., Pyke, S. D. M., Gallimore, J. R. and Pepys, M. B. (1997) Production of C reactive protein and risk of coronary events in stable and unstable angina. Lancet, 349, pp. 462-466.
16. He, J., Vupputuri, S., Allen, K., Prerost, M. R., Hughes, J. and Whelton, P. K. (1999) Passive smoking and the risk of coronary heart disease: A meta-analysis of epidemiologic studies. New England Journal of Medicine, 340:12, pp. 920-926.
17. Homish, G. G. and Leonard, K. E. (2005) Spousal influence on smoking behaviours in a US community sample of newly married couples. Social Science and Medicine, 61:12, pp. 2557-2567.
18. Kiechl, S., Werner, P., Egger, G., Oberhollenzer, F., Mayr, M., Xu, Q., Poewe, W. and Willeit, J. (2002) Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: Prospective results from the Bruneck Study. Stroke, 33:9, pp. 2170-2176.
19. Koenig, W., Sund, M., Frohlich, M., Lowel, H., Doring, A., Hutchinson, W. I. and Pepys, M. B. (1999) C reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (MONI-toring trends and determinants in Cardiovascular disease) Ausberg Cohort Study, 1984 to 1992. Circulation, 99, pp. 237-242.
20. Kuller, W., Tracy, R., Shaten, J. and Meilahn, E. N. (1996) For the MRFIT research group: Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. American Journal of Epidemiology, 144, pp. 537-547.
21. Lowe, G. D. O., Yarnell, J. W. G., Rumley, A., Bainton, D. and Sweetnam, P. M. (2001) C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell Study. Ateriosclerosis, Thrombosis, and Vascular Biology, 21, pp. 603-610.
22. Meade, T. W., Imeson, J. and Stirling, Y. (1987) Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet, 2, pp. 986-988.
23. Ohsawa, M., Okayama, A., Nakamura, M., Onoda, T., Kato, K., Itai, K., Yoshida, Y., Ogawa, A., Kawamura, K. and Hiramori, K. (2005) CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Preventative Medicine, 41, pp. 651-656.
24. Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, J., Masoura, C., Toutouzas, P. and Stefanadis, C. (2004) Effect of exposure to secondhand smoke on markers of inflammation: The ATTICA study. American Journal of Medicine, 116, pp. 145-150.
25. Raupach, T., Schafer, K., Konstantinides, S. and Andreas, S. (2006) Secondhand smoke as an acute threat for the cardiovascular system: A change in paradigm. European Heart Journal, 27:4, pp. 386-392.
26. Scottish Executive (2004) Scottish Index of Multiple Deprivation 2004.
27. Scottish Executive (2005) Scottish Health Survey 2003.
28. Tappia, P. S., Troughton, K. L., Langley-Evans, S. C. and Grimble, R. F. (1995) Cigarette smoking influences cytokine production and antioxidant defense. Clinical Science, 88, pp. 485-489.
29. Tracy, R. P., Psoley, B. M., Macy, E., Bovil, E. G., Custman, M., Cornell, E. S. and Kuller, L. H. (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular risk factors and sub-clinical disease in healthy elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, pp. 2167-2176.
30. Tunstall-Pedoe, H., Brown, C. A., Woodward, M. and Tavendale, R. (1995) Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish Heart Health Study. Journal of Epidemiology and Community Health, 49, pp. 139-143.
31. Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., Lennon, L. and Whincup, P. H. (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetes with and without coronary heart disease. Diabetologia, 47, pp. 1557-1565.
32. Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., Lennon, L. and Whincup, P. H. (2005) Associations between cigarette smoking, pipe/cigar smoking, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26, pp. 1765-1773.
33. Whincup, P. H., Gilg, J. A., Emberson, J. R., Jarvis, M. J., Feyerabend, C., Bryant, A., Walker, M. and Cook, D. G. (2004) Passive smoking and risk of coronary heart disease and stroke: Prospective study with cotinine measurement. British Medical Journal, 329:7459, pp. 200-205.
34. Yasue, H., Hirai, N., Mizuno, Y., Harada, E., Itoh, T., Yoshjmura, M., Kugiyama, K. and Ogawa, H. (2006) Low-grade inflammation, thrombogenicity, and atherogenetic lipid profile in cigarette smokers. Circulation, 70:1, pp. 8-13.
35. Zhang, J., Liu, Y., Shi, J., Larson, D. F. and Watson, R. R. (2002) Side-stream cigarette smoke induces dose response in systemic inflammatory cytokine production and oxidative stress. Experimental Biology and Medicine, 227, pp. 823-829.